DN200434 Inhibits Vascular Smooth Muscle Cell Proliferation and Prevents Neointima Formation in Mice after Carotid Artery Ligation

Background Excessive proliferation and migration of vascular smooth muscle cells (VSMCs), which contributes to the development of occlusive vascular diseases, requires elevated mitochondrial oxidative phosphorylation to meet the increased requirements for energy and anabolic precursors. Therefore, t...

Full description

Bibliographic Details
Main Authors: Sudeep Kumar, Jonghwa Jin, Hyeon Young Park, Mi-Jin Kim, Jungwook Chin, Sungwoo Lee, Jina Kim, Jung-Guk Kim, Yeon-Kyung Choi, Keun-Gyu Park
Format: Article
Language:English
Published: Korean Endocrine Society 2022-10-01
Series:Endocrinology and Metabolism
Subjects:
Online Access:http://www.e-enm.org/upload/pdf/enm-2022-1462.pdf
_version_ 1828158667571068928
author Sudeep Kumar
Jonghwa Jin
Hyeon Young Park
Mi-Jin Kim
Jungwook Chin
Sungwoo Lee
Jina Kim
Jung-Guk Kim
Yeon-Kyung Choi
Keun-Gyu Park
author_facet Sudeep Kumar
Jonghwa Jin
Hyeon Young Park
Mi-Jin Kim
Jungwook Chin
Sungwoo Lee
Jina Kim
Jung-Guk Kim
Yeon-Kyung Choi
Keun-Gyu Park
author_sort Sudeep Kumar
collection DOAJ
description Background Excessive proliferation and migration of vascular smooth muscle cells (VSMCs), which contributes to the development of occlusive vascular diseases, requires elevated mitochondrial oxidative phosphorylation to meet the increased requirements for energy and anabolic precursors. Therefore, therapeutic strategies based on blockade of mitochondrial oxidative phosphorylation are considered promising for treatment of occlusive vascular diseases. Here, we investigated whether DN200434, an orally available estrogen receptor-related gamma inverse agonist, inhibits proliferation and migration of VSMCs and neointima formation by suppressing mitochondrial oxidative phosphorylation. Methods VSMCs were isolated from the thoracic aortas of 4-week-old Sprague-Dawley rats. Oxidative phosphorylation and the cell cycle were analyzed in fetal bovine serum (FBS)- or platelet-derived growth factor (PDGF)-stimulated VSMCs using a Seahorse XF-24 analyzer and flow cytometry, respectively. A model of neointimal hyperplasia was generated by ligating the left common carotid artery in male C57BL/6J mice. Results DN200434 inhibited mitochondrial respiration and mammalian target of rapamycin complex 1 activity and consequently suppressed FBS- or PDGF-stimulated proliferation and migration of VSMCs and cell cycle progression. Furthermore, DN200434 reduced carotid artery ligation-induced neointima formation in mice. Conclusion Our data suggest that DN200434 is a therapeutic option to prevent the progression of atherosclerosis.
first_indexed 2024-04-11T23:48:33Z
format Article
id doaj.art-5b5612ebfc1b424b9c7851e123404bde
institution Directory Open Access Journal
issn 2093-596X
2093-5978
language English
last_indexed 2024-04-11T23:48:33Z
publishDate 2022-10-01
publisher Korean Endocrine Society
record_format Article
series Endocrinology and Metabolism
spelling doaj.art-5b5612ebfc1b424b9c7851e123404bde2022-12-22T03:56:34ZengKorean Endocrine SocietyEndocrinology and Metabolism2093-596X2093-59782022-10-0137580080910.3803/EnM.2022.14622332DN200434 Inhibits Vascular Smooth Muscle Cell Proliferation and Prevents Neointima Formation in Mice after Carotid Artery LigationSudeep Kumar0Jonghwa Jin1Hyeon Young Park2Mi-Jin Kim3Jungwook Chin4Sungwoo Lee5Jina Kim6Jung-Guk Kim7Yeon-Kyung Choi8Keun-Gyu Park9 Research Institute of Aging and Metabolism, Kyungpook National University, Daegu, Korea Department of Internal Medicine, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Korea Department of Biomedical Science, Graduate School, Kyungpook National University, Daegu, Korea Department of Internal Medicine, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Korea New Drug Development Center, Daegu Gyeongbuk Medical Innovation Foundation, Daegu, Korea New Drug Development Center, Daegu Gyeongbuk Medical Innovation Foundation, Daegu, Korea New Drug Development Center, Daegu Gyeongbuk Medical Innovation Foundation, Daegu, Korea Department of Internal Medicine, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Korea Research Institute of Aging and Metabolism, Kyungpook National University, Daegu, Korea Research Institute of Aging and Metabolism, Kyungpook National University, Daegu, KoreaBackground Excessive proliferation and migration of vascular smooth muscle cells (VSMCs), which contributes to the development of occlusive vascular diseases, requires elevated mitochondrial oxidative phosphorylation to meet the increased requirements for energy and anabolic precursors. Therefore, therapeutic strategies based on blockade of mitochondrial oxidative phosphorylation are considered promising for treatment of occlusive vascular diseases. Here, we investigated whether DN200434, an orally available estrogen receptor-related gamma inverse agonist, inhibits proliferation and migration of VSMCs and neointima formation by suppressing mitochondrial oxidative phosphorylation. Methods VSMCs were isolated from the thoracic aortas of 4-week-old Sprague-Dawley rats. Oxidative phosphorylation and the cell cycle were analyzed in fetal bovine serum (FBS)- or platelet-derived growth factor (PDGF)-stimulated VSMCs using a Seahorse XF-24 analyzer and flow cytometry, respectively. A model of neointimal hyperplasia was generated by ligating the left common carotid artery in male C57BL/6J mice. Results DN200434 inhibited mitochondrial respiration and mammalian target of rapamycin complex 1 activity and consequently suppressed FBS- or PDGF-stimulated proliferation and migration of VSMCs and cell cycle progression. Furthermore, DN200434 reduced carotid artery ligation-induced neointima formation in mice. Conclusion Our data suggest that DN200434 is a therapeutic option to prevent the progression of atherosclerosis.http://www.e-enm.org/upload/pdf/enm-2022-1462.pdfmuscle, smooth, vascularneointimaestrogen-related receptor gamma proteinoxidative phosphorylationmechanistic target of rapamycin complex 1
spellingShingle Sudeep Kumar
Jonghwa Jin
Hyeon Young Park
Mi-Jin Kim
Jungwook Chin
Sungwoo Lee
Jina Kim
Jung-Guk Kim
Yeon-Kyung Choi
Keun-Gyu Park
DN200434 Inhibits Vascular Smooth Muscle Cell Proliferation and Prevents Neointima Formation in Mice after Carotid Artery Ligation
Endocrinology and Metabolism
muscle, smooth, vascular
neointima
estrogen-related receptor gamma protein
oxidative phosphorylation
mechanistic target of rapamycin complex 1
title DN200434 Inhibits Vascular Smooth Muscle Cell Proliferation and Prevents Neointima Formation in Mice after Carotid Artery Ligation
title_full DN200434 Inhibits Vascular Smooth Muscle Cell Proliferation and Prevents Neointima Formation in Mice after Carotid Artery Ligation
title_fullStr DN200434 Inhibits Vascular Smooth Muscle Cell Proliferation and Prevents Neointima Formation in Mice after Carotid Artery Ligation
title_full_unstemmed DN200434 Inhibits Vascular Smooth Muscle Cell Proliferation and Prevents Neointima Formation in Mice after Carotid Artery Ligation
title_short DN200434 Inhibits Vascular Smooth Muscle Cell Proliferation and Prevents Neointima Formation in Mice after Carotid Artery Ligation
title_sort dn200434 inhibits vascular smooth muscle cell proliferation and prevents neointima formation in mice after carotid artery ligation
topic muscle, smooth, vascular
neointima
estrogen-related receptor gamma protein
oxidative phosphorylation
mechanistic target of rapamycin complex 1
url http://www.e-enm.org/upload/pdf/enm-2022-1462.pdf
work_keys_str_mv AT sudeepkumar dn200434inhibitsvascularsmoothmusclecellproliferationandpreventsneointimaformationinmiceaftercarotidarteryligation
AT jonghwajin dn200434inhibitsvascularsmoothmusclecellproliferationandpreventsneointimaformationinmiceaftercarotidarteryligation
AT hyeonyoungpark dn200434inhibitsvascularsmoothmusclecellproliferationandpreventsneointimaformationinmiceaftercarotidarteryligation
AT mijinkim dn200434inhibitsvascularsmoothmusclecellproliferationandpreventsneointimaformationinmiceaftercarotidarteryligation
AT jungwookchin dn200434inhibitsvascularsmoothmusclecellproliferationandpreventsneointimaformationinmiceaftercarotidarteryligation
AT sungwoolee dn200434inhibitsvascularsmoothmusclecellproliferationandpreventsneointimaformationinmiceaftercarotidarteryligation
AT jinakim dn200434inhibitsvascularsmoothmusclecellproliferationandpreventsneointimaformationinmiceaftercarotidarteryligation
AT junggukkim dn200434inhibitsvascularsmoothmusclecellproliferationandpreventsneointimaformationinmiceaftercarotidarteryligation
AT yeonkyungchoi dn200434inhibitsvascularsmoothmusclecellproliferationandpreventsneointimaformationinmiceaftercarotidarteryligation
AT keungyupark dn200434inhibitsvascularsmoothmusclecellproliferationandpreventsneointimaformationinmiceaftercarotidarteryligation